Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
RHYTHM PHARM RG (NQ: RYTM)
32.75 USD  -0.16 (-0.49%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jun 22, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 966,976
Open 32.60
Bid (Size) 32.00 (100)
Ask (Size) 34.19 (100)
Prev. Close 32.91
Today's Range 31.69 - 32.99
52wk Range 16.80 - 34.99
Shares Outstanding 27,530,184
Dividend Yield N/A
Performance
YTD
+16.96%
+16.96%
1 Month
+8.16%
+8.16%
3 Month
+55.29%
+55.29%
6 Month
+11.89%
+11.89%
1 Year
+9.17%
+9.17%
Top News
More News
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic disorders of obesity, today... Read More
from GlobeNewswire News Releases
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic disorders of obesity, today... Read More
from GlobeNewswire News Releases
More News
Read More
Rhythm Pharmaceuticals Announces New Topline Clinical Data from Ongoing Phase 2 Basket Studies Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
from GlobeNewswire News Releases
Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
from GlobeNewswire News Releases
Factors of Influence in 2018, Key Indicators and Opportunity within BiondVax Pharmaceuticals, MercadoLibre, 1-800 FLOWERS.COM, Redhill Biopharma, Mountain Province Diamonds, and Rhythm Pharmaceuticals
from GlobeNewswire News Releases
Rhythm Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
from GlobeNewswire News Releases
Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results
from GlobeNewswire News Releases
Rhythm Pharmaceuticals Announces Nature Medicine Publication of Longer-Term Data from Phase 2 Study of Setmelanotide for Treatment of LEPR Deficiency Obesity
from GlobeNewswire News Releases
Rhythm Pharmaceuticals to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
from GlobeNewswire News Releases
5 Stocks Moving In Thursday's After-Hours Session
category AQMS , After/Hours Center , BLCM , and 8 more.
from Benzinga
Consolidated Research: 2018 Summary Expectations for Ctrip.com International, JA Solar Holdings, Co., Oaktree Specialty Lending, Rhythm Pharmaceuticals, Cellectis S.A, and Travelport Worldwide — Funda
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.